company background image
6869 logo

Sysmex TSE:6869 Stock Report

Last Price

JP¥2.69k

Market Cap

JP¥1.7t

7D

-4.3%

1Y

-5.6%

Updated

28 Mar, 2024

Data

Company Financials +

6869 Stock Overview

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan.

6869 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance2/6
Financial Health5/6
Dividends3/6

Rewards

Risk Analysis

No risks detected for 6869 from our risk checks.

Sysmex Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sysmex
Historical stock prices
Current Share PriceJP¥2,687.50
52 Week HighJP¥3,480.00
52 Week LowJP¥2,236.00
Beta0.53
1 Month Change-2.08%
3 Month Change2.60%
1 Year Change-5.61%
3 Year Change-31.99%
5 Year Change23.83%
Change since IPO2,587.50%

Recent News & Updates

Sysmex Corporation's (TSE:6869) P/E Is On The Mark

Feb 28
Sysmex Corporation's (TSE:6869) P/E Is On The Mark

Recent updates

Sysmex Corporation's (TSE:6869) P/E Is On The Mark

Feb 28
Sysmex Corporation's (TSE:6869) P/E Is On The Mark

Shareholder Returns

6869JP Medical EquipmentJP Market
7D-4.3%-1.3%1.7%
1Y-5.6%24.2%37.6%

Return vs Industry: 6869 underperformed the JP Medical Equipment industry which returned 24.2% over the past year.

Return vs Market: 6869 underperformed the JP Market which returned 37.6% over the past year.

Price Volatility

Is 6869's price volatile compared to industry and market?
6869 volatility
6869 Average Weekly Movement4.2%
Medical Equipment Industry Average Movement3.8%
Market Average Movement3.9%
10% most volatile stocks in JP Market8.4%
10% least volatile stocks in JP Market2.1%

Stable Share Price: 6869 has not had significant price volatility in the past 3 months.

Volatility Over Time: 6869's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19689,500Hisashi Ietsuguhttps://www.sysmex.co.jp

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

Sysmex Corporation Fundamentals Summary

How do Sysmex's earnings and revenue compare to its market cap?
6869 fundamental statistics
Market capJP¥1.68t
Earnings (TTM)JP¥45.06b
Revenue (TTM)JP¥438.28b

37.2x

P/E Ratio

3.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6869 income statement (TTM)
RevenueJP¥438.28b
Cost of RevenueJP¥205.29b
Gross ProfitJP¥232.99b
Other ExpensesJP¥187.93b
EarningsJP¥45.06b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 09, 2024

Earnings per share (EPS)72.29
Gross Margin53.16%
Net Profit Margin10.28%
Debt/Equity Ratio6.1%

How did 6869 perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

38%

Payout Ratio

Does 6869 pay a reliable dividends?

See 6869 dividend history and benchmarks
When do you need to buy 6869 by to receive an upcoming dividend?
Sysmex dividend dates
Ex Dividend DateMar 28 2024
Dividend Pay DateJun 26 2024
Days until Ex dividend1 day
Days until Dividend pay date89 days

Does 6869 pay a reliable dividends?

See 6869 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.